Minerva Neuroscience will host an in-person KOL event to discuss rolperidone for negative symptoms of schizophrenia.
Minerva Neuroscience will host an in-person KOL event to discuss rolperidone for negative symptoms of schizophrenia.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in